View All Upcoming Sponsored Webinars
Recorded March 21, 2016
This webinar will describe a groundbreaking new technique published recently in Analytical Chemistry for measuring single cancer cells. The study, conducted by Dr. David Walt and his research group at Tufts University, demonstrates that the ultrasensitive Simoa technology makes it possible to quantify phenotypic responses of individual prostate cancer cells, a technique that could be useful for understanding fundamental biology and may eventually enable both earlier disease detection and targeted therapy.
Dr. David Walt
Professor of Chemistry
David R. Walt is Robinson Professor of Chemistry at Tufts University and a Howard Hughes Medical Institute Professor. Dr. Walt is a member of the U.S. National Academy of Engineering, a fellow of the American Association for the Advancement of Science, and a fellow of the American Institute for Medical and Biological Engineering. Dr. Walt serves on the Editorial Advisory Board of several journals including Analytical Chemistry, Analytical and Bioanalytical Chemistry, Sensor Letters, and the Indian Journal of Biotechnology. He served as Executive Editor of Applied Biochemistry and Biotechnology and was a founding member of the Editorial Advisory Board for the Journal of Combinatorial Chemistry. Dr. Walt is the Scientific Founder and Chair of the Scientific Advisory Board at Quanterix, and a Director of Illumina. He has received numerous national and international awards and honors recognizing his work including a National Science Foundation Special Creativity Award, The Biosensors and Bioelectronics Award, and the Samuel R. Scholes Award in Glass Science. Dr. Walt has received the Tufts Outstanding Faculty Award twice in addition to the Distinguished Research Award. He has published over 200 papers, holds over 45 patents, and has given hundreds of invited lectures and scientific presentations. Dr. Walt received his Ph.D. in Chemical Biology from SUNY at Stony Brook and a B.S. in Chemistry from the University of Michigan.
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesReports & Market Researchbarnett educational servicesHealthtech PublishingKnowledge Foundation professional services
executive teamtestimonialschi timelinemailing listcareers